Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

Clinical trial NCT03880123 · WITHDRAWN

Trial details

NCT number: NCT03880123
Sponsor: Matthew Ingham
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Liposarcoma Malignant Peripheral Nerve Sheath Tumors Alveolar Soft Part Sarcoma Ewing Sarcoma Sarcoma

Start date: 2020-11-01
Primary completion: 2020-11-24
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.